The Latest Headlines at American Banking and Market News
Don Schena Sells 10,000 Shares of WideOpenWest, Inc. (NYSE:WOW) Stock
WideOpenWest, Inc. (NYSE:WOW – Get Free Report) insider Don Schena sold 10,000 shares of the firm’s stock in a transaction on Friday, May 3rd. The shares were sold at an average price of $5.00, for a total transaction of... More of this article »
Rajesh Pankaj Sells 650 Shares of InterDigital, Inc. (NASDAQ:IDCC) Stock
InterDigital, Inc. (NASDAQ:IDCC – Get Free Report) CTO Rajesh Pankaj sold 650 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $103.87, for a total transaction... More of this article »
Barrington Research Weighs in on Henry Schein, Inc.’s Q2 2024 Earnings (NASDAQ:HSIC)
Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Analysts at Barrington Research reduced their Q2 2024 earnings estimates for shares of Henry Schein in a research report issued to clients and investors on Wednesday,... More of this article »
Brokers Set Expectations for Henry Schein, Inc.’s Q2 2024 Earnings (NASDAQ:HSIC)
Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Research analysts at William Blair reduced their Q2 2024 earnings per share estimates for Henry Schein in a report issued on Tuesday, May 7th. William Blair analyst B.... More of this article »
Singular Research Comments on FSD Pharma Inc.’s Q1 2024 Earnings (CVE:HUG)
FSD Pharma Inc. (CVE:HUG – Free Report) – Singular Research issued their Q1 2024 earnings per share estimates for FSD Pharma in a report issued on Tuesday, May 7th. Singular Research analyst B. Cook forecasts that the... More of this article »
Q2 2024 Earnings Forecast for Novanta Inc. Issued By William Blair (NASDAQ:NOVT)
Novanta Inc. (NASDAQ:NOVT – Free Report) – Analysts at William Blair lowered their Q2 2024 earnings per share estimates for shares of Novanta in a note issued to investors on Tuesday, May 7th. William Blair analyst... More of this article »
Q2 2024 Earnings Estimate for Stoke Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:STOK)
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Analysts at Leerink Partnrs reduced their Q2 2024 earnings per share estimates for Stoke Therapeutics in a report released on Monday, May 6th. Leerink Partnrs analyst... More of this article »
Merit Financial Group LLC Reduces Position in Edwards Lifesciences Co. (NYSE:EW)
Merit Financial Group LLC lowered its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 33.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 4,032... More of this article »
Generac Holdings Inc. (NYSE:GNRC) Shares Sold by Merit Financial Group LLC
Merit Financial Group LLC trimmed its holdings in Generac Holdings Inc. (NYSE:GNRC – Free Report) by 16.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The... More of this article »
Merit Financial Group LLC Sells 125 Shares of HCA Healthcare, Inc. (NYSE:HCA)
Merit Financial Group LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 9.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,181 shares of the... More of this article »
Merit Financial Group LLC Lowers Holdings in Consolidated Edison, Inc. (NYSE:ED)
Merit Financial Group LLC trimmed its position in shares of Consolidated Edison, Inc. (NYSE:ED – Free Report) by 8.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 4,033 shares... More of this article »
Merit Financial Group LLC Has $383,000 Stock Position in Devon Energy Co. (NYSE:DVN)
Merit Financial Group LLC lowered its holdings in shares of Devon Energy Co. (NYSE:DVN – Free Report) by 99.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission... More of this article »
Stokes Family Office LLC Has $8.20 Million Stock Position in JPMorgan Chase & Co. (NYSE:JPM)
Stokes Family Office LLC cut its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 28.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 48,189 shares of the financial services... More of this article »